Glenmark Specialty S.A.,a subsidiary of Glenmark Pharmaceuticals Ltd. that is fully owned, announced that its innovative nasal spray for allergic rhinitis, Ryaltris Compound Nasal Spray (GSP 301 NS), has received approval from China
Marksans Pharma experienced an increase of 1.94%, reaching Rs 186.30, following the announcement that it received zero observations during a current Good Manufacturing Practice (cGMP) inspection conducted by the US Food and Drug Administration
The Johnson & Johnson's (J&J) CAPLYTA (lumateperone) product has been given a green light by the U.S. Food and Drug Administration (USFDA) to be used as adjunctive therapy with antidepressants for adult major depressive disorder
The transition from volume-led growth to value- and innovation-led expansion is currently the defining trend of the Indian pharmaceutical business
Lupin has unveiled an ambitious tactical plan aimed at accelerating its growth through a strong product pipeline, widened market reach, and improved financial health. The company's latest update emphasizes a tightly managed approach
Torrent Pharmaceuticals got the green light from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) to produce and sell Prucalopride Oral Solution (0.2 mg/mL).
In order to guarantee that innovative tuberculosis (TB) vaccines reach adults and adolescents in high-burden nations, a new WHO report that was released on the fringes of the G20 Health Ministers Meeting in Limpopo, South Africa, argues for daring
Marksans Pharma Limited has announced that its wholly owned subsidiary in the United Kingdom, Relonchem Limited, has obtained Marketing Authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its product Exemestane 2
Ahmedabad-based Intas Pharmaceuticals has reinforced its position as a leading player in the Indian Pharmaceutical Market (IPM), maintaining the 6th rank for both September 2025 and the Moving Annual Turnover (MAT) period. The company reported...
India pharmaceutical industry is going next-generation cell and gene therapy decisively, inspiring cancer treatment accessibility at a lower cost.
.jpg)
.jpg)
, CDSCO.jpg)